These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 3153321

  • 1. Congenital nephrogenic diabetes insipidus-vasopressin and prostaglandins in response to treatment with hydrochlorothiazide and indomethacin.
    Rascher W, Rosendahl W, Henrichs IA, Maier R, Seyberth HW.
    Pediatr Nephrol; 1987 Jul; 1(3):485-90. PubMed ID: 3153321
    [Abstract] [Full Text] [Related]

  • 2. Response to indomethacin and hydrochlorothiazide in nephrogenic diabetes insipidus.
    Monnens L, Jonkman A, Thomas C.
    Clin Sci (Lond); 1984 Jun; 66(6):709-15. PubMed ID: 6723207
    [Abstract] [Full Text] [Related]

  • 3. Effect of hydrochlorothiazide and indomethacin treatment on renal function in nephrogenic diabetes insipidus.
    Jakobsson B, Berg U.
    Acta Paediatr; 1994 May; 83(5):522-5. PubMed ID: 8086732
    [Abstract] [Full Text] [Related]

  • 4. Comparative therapeutic benefit of indomethacin, hydrochlorothiazide, and acetyl-salicylic acid in a patient with nephrogenic diabetes insipidus.
    Vierhapper H, Jörg J, Favre L, Vallotton MB, Waldhäusl W.
    Acta Endocrinol (Copenh); 1984 Jul; 106(3):311-6. PubMed ID: 6588700
    [Abstract] [Full Text] [Related]

  • 5. The renin-aldosterone system in nephrogenic diabetes insipidus and the influence of hydrochlorothiazide and indomethacin.
    Andersen O, Jacobsen BB.
    Acta Paediatr Scand; 1983 Sep; 72(5):717-20. PubMed ID: 6637470
    [Abstract] [Full Text] [Related]

  • 6. Amiloride-hydrochlorothiazide versus indomethacin-hydrochlorothiazide in the treatment of nephrogenic diabetes insipidus.
    Knoers N, Monnens LA.
    J Pediatr; 1990 Sep; 117(3):499-502. PubMed ID: 2391611
    [No Abstract] [Full Text] [Related]

  • 7. Hydrochlorothiazide-amiloride in the treatment of congenital nephrogenic diabetes insipidus.
    Alon U, Chan JC.
    Am J Nephrol; 1985 Sep; 5(1):9-13. PubMed ID: 3970081
    [Abstract] [Full Text] [Related]

  • 8. Renal prostaglandins and water balance: studies in normal volunteer subjects and in patients with central diabetes insipidus.
    Düsing R, Herrmann R, Glänzer K, Vetter H, Overlack A, Kramer HJ.
    Clin Sci (Lond); 1981 Jul; 61(1):61-7. PubMed ID: 6265142
    [Abstract] [Full Text] [Related]

  • 9. Amelioration of polyuria in nephrogenic diabetes insipidus due to aquaporin-2 deficiency.
    Hochberg Z, Even L, Danon A.
    Clin Endocrinol (Oxf); 1998 Jul; 49(1):39-44. PubMed ID: 9797845
    [Abstract] [Full Text] [Related]

  • 10. [Long-term course of 6 boys with congenital nephrogenic diabetes insipidus].
    Kaulitz R, Brodehl J.
    Klin Padiatr; 1989 Jul; 201(6):425-30. PubMed ID: 2601280
    [Abstract] [Full Text] [Related]

  • 11. Role of renal prostaglandins during antidiuresis and water diuresis in man.
    Walker RM, Brown RS, Stoff JS.
    Kidney Int; 1982 Feb; 21(2):365-70. PubMed ID: 6951096
    [Abstract] [Full Text] [Related]

  • 12. Mechanism of action of indomethacin in tubular defects.
    Usberti M, Pecoraro C, Federico S, Cianciaruso B, Guida B, Romano A, Grumetto L, Carbonaro L.
    Pediatrics; 1985 Mar; 75(3):501-7. PubMed ID: 3856211
    [Abstract] [Full Text] [Related]

  • 13. Nephrogenic diabetes insipidus: treat with caution.
    Boussemart T, Nsota J, Martin-Coignard D, Champion G.
    Pediatr Nephrol; 2009 Sep; 24(9):1761-3. PubMed ID: 19373493
    [Abstract] [Full Text] [Related]

  • 14. Nephrogenic diabetes insipidus: clinical and pathophysiological aspects.
    Niaudet P, Dechaux M, Trivin C, Loirat C, Broyer M.
    Adv Nephrol Necker Hosp; 1984 Sep; 13():247-60. PubMed ID: 6089520
    [No Abstract] [Full Text] [Related]

  • 15. Evidence for intact V1-vasopressin receptors in congenital nephrogenic diabetes insipidus.
    Knoers N, Janssens PM, Goertz J, Monnens LA.
    Eur J Pediatr; 1992 May; 151(5):381-3. PubMed ID: 1396896
    [Abstract] [Full Text] [Related]

  • 16. Successful treatment with hydrochlorothiazide and amiloride in an infant with congenital nephrogenic diabetes insipidus.
    Uyeki TM, Barry FL, Rosenthal SM, Mathias RS.
    Pediatr Nephrol; 1993 Oct; 7(5):554-6. PubMed ID: 8251321
    [Abstract] [Full Text] [Related]

  • 17. The effect of inhibition of prostaglandin synthesis on free water and osmolar clearances in patients with hereditary nephrogenic diabetes insipidus.
    Blachar Y, Zadik Z, Shemesh M, Kaplan BS, Levin S.
    Int J Pediatr Nephrol; 1980 Mar; 1(1):48-52. PubMed ID: 7343530
    [No Abstract] [Full Text] [Related]

  • 18. Transient vasopressin-resistant diabetes insipidus of pregnancy.
    Ford SM, Lumpkin HL.
    Obstet Gynecol; 1986 Nov; 68(5):726-8. PubMed ID: 3763091
    [Abstract] [Full Text] [Related]

  • 19. Treatment of nephrogenic diabetes insipidus with hydrochlorothiazide and amiloride.
    Kirchlechner V, Koller DY, Seidl R, Waldhauser F.
    Arch Dis Child; 1999 Jun; 80(6):548-52. PubMed ID: 10332005
    [Abstract] [Full Text] [Related]

  • 20. [Indomethacin therapy of children with nephrogenic diabetes insipidus].
    Túri S, László A, Mérth I.
    Orv Hetil; 1980 Feb 10; 121(6):337-40. PubMed ID: 7366992
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.